Why lasting weight maintenance requires more than calorie control, integrating diet quality, movement, circadian biology, ...
Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...
Glass Cannon Pictos are special combat modifiers that boost offensive stats such as raw damage, critical chance, or ability ...
MedPage Today on MSN
DVT Assessment Strategy Safely Expands Rule-Out
A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...
Tea may offer powerful health benefits, but how it is prepared and consumed matters. Tea has a long history as both a ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
At its core, conservation is about behavior change. Yet few organizations have put in place the structure, standards, and ...
Platform-specific achievement systems transformed an isolated gameplay preference into a visible, competitive subculture. What emerged wasn’t just a playstyle but an ecosystem of tracking tools, ...
HHS Secretary Robert F. Kennedy Jr.s CDC just funneled a $1.6 million dollar grant to researchers to carry out an unethical and scientifically unjustified randomized clinical trial of the birth dose o ...
In summary, we are making significant strides in advancing BOT/BAL and positioning Agenus for long-term success. I'll now ...
This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...
Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results